2023 Update of the Japanese Heart Failure Society Scientific Statement on BNP and NT-proBNP Levels in Heart Failure Practice
Masatoshi Minamisawa, Toshihisa Anzai, Takayuki Inomata, Koichiro Kinugawa, Yasushi Sakata, Naoki Sato, Hiroyuki Tsutsui, Kazuhiro Yamamoto, Michihiro Yoshimura, Yoshihiko Saito, Koichiro Kuwahara
Abstract
This revised 2023 statement on blood brain (B-type) natriuretic peptide (BNP) and N-terminal prohormone of brain (B-type) natriuretic peptide (NT-proBNP) represents an expert consensus that aims to enhance efficient referral from general practitioners or non-cardiovascular specialists, providing a comprehensive, up-to-date perspective on BNP and NT-proBNP in the diagnosis and management of heart failure, with a focus on the following two major modifications: (1) Changes regarding cutoff values for BNP and NT-proBNP (criteria for heart failure diagnosis and referral criteria to cardiovascular specialists); and (2) Content related to heart failure management using BNP and NT-proBNP (BNP-guided therapy).